Table 1.
Investigation finding (initial, after empirical therapy, and after anti-TB therapy).
| Investigation | Initial findings | Follow-up after empirical therapy | Follow-up after antitubercular therapy |
|---|---|---|---|
| Hb (g/dL) | 9.9 | 11.6 | 12.5 |
| Erythrocyte sedimentation rate (ESR) (at 1st hour) | 82 | 58 | 05 |
| Wbc (per mm3/cmm) | 15,500 | 8000 | 8800 |
| CRP (mg/L) | 39 | 5 | 0.85 |
| Sgpt (U/L) | 25 | 20 | |
| S creatinine (mg/dL) | 0.93 | 0.96 | |
| Uric acid (mg/L) | 5.89 | ||
| Rheumatoid factor | Negative | ||
| Duplex study of the affected lower limb | Normal arterial and venous system Baker's cyst present |
||
| Montaux test (MT) | Positive (14 mm) | ||
| X-ray sacroiliac joint–modified Ferguson view | Osteitis condensus illi (bilateral) | ||
| ANA | Negative | ||
| ANTI DS DNA | Negative | ||
| RBS (mmol/L) | 6 | ||
| X-ray knee standing both view | Normal |